Direct Answer
UnitedHealth Group (NYSE: UNH) first listed on the New York Stock Exchange in 1977 and took its current corporate form in 1998. The company has completed four stock splits since listing, with a cumulative factor of 9x. UNH joined the Dow Jones Industrial Average on September 24, 2012, replacing Kraft Foods, and has at times been the single largest point influence on the price-weighted index due to its high per-share price. UnitedHealth has raised its quarterly dividend for more than 15 consecutive years and returned approximately $14.7 billion to shareholders in fiscal year 2024 through combined dividends and buybacks.
NYSE listing and corporate history
UnitedHealth Group first listed on the New York Stock Exchange in 1977. The company reorganized and rebranded as UnitedHealth Group in 1998, consolidating its managed care operations under a single holding company structure. Its SEC Central Index Key (CIK) is 0000731766. The stock trades under the ticker symbol UNH and has remained one of the largest healthcare listings on the NYSE by market capitalization.
UnitedHealth Group operates two primary business segments: UnitedHealthcare, which provides health benefits, and Optum, which delivers health services including pharmacy benefit management, analytics, and care delivery. This diversified structure distinguishes UNH from pure health insurers and has supported sustained revenue and earnings growth across economic cycles.
| Listing Detail | Value |
|---|---|
| Exchange | New York Stock Exchange (NYSE) |
| Ticker | UNH |
| SEC CIK | 0000731766 |
| Original NYSE listing | 1977 |
| Current corporate form established | 1998 (UnitedHealth Group rebranding) |
Stock split history
UnitedHealth Group has completed four stock splits since its original listing. All four occurred during the 1990s as the managed care sector grew rapidly and the company's share price rose to levels that made additional splits attractive for retail accessibility. No splits have occurred since January 2000.
| Split Date | Split Ratio | Cumulative Factor (after split) |
|---|---|---|
| May 1, 1992 | 2-for-1 | 2x |
| November 1, 1995 | 3-for-2 | 3x |
| May 14, 1997 | 3-for-2 | 4.5x |
| January 10, 2000 | 2-for-1 | 9x |
The cumulative split factor of 9x means that one share held before the May 1992 split became nine shares after all four splits. The 3-for-2 splits in 1995 and 1997 each increased the share count by 50 percent while reducing the price proportionally. The final 2-for-1 split in January 2000 occurred near the peak of the late-1990s managed care expansion. Since January 2000, UnitedHealth has not announced additional splits, and the share price has risen substantially from its post-split level as the business expanded through the Optum build-out and the Affordable Care Act era.
Dow Jones Industrial Average membership
UnitedHealth Group was added to the Dow Jones Industrial Average on September 24, 2012, replacing Kraft Foods. The inclusion reflected UNH's emergence as the largest U.S. health insurer by revenue and the growing weight of healthcare spending in the broader economy.
Because the Dow is a price-weighted index, each component's contribution to daily index moves is proportional to its per-share price rather than its market capitalization. UNH's share price of $550 or more in recent years has at times made it the single largest daily influence on the DJIA. A $1 move in UNH produces a larger point change in the Dow than the same $1 move in a lower-priced component such as Intel or Walgreens. This arithmetic means UNH earnings surprises or news events that shift its price by a few percent can visibly swing the Dow's headline level for the day.
| DJIA Event | Detail |
|---|---|
| Added to Dow | September 24, 2012 |
| Replaced | Kraft Foods |
| Index weighting basis | Price-weighted (per-share price determines influence) |
| Price influence context | At $550+ per share, UNH has at times been the single largest DJIA point driver |
Dividend history
UnitedHealth Group has raised its dividend for more than 15 consecutive years and is working toward Dividend Aristocrat status, which requires 25 consecutive years of annual dividend increases. As of fiscal year 2024, the quarterly dividend was $2.10 per share, or $8.40 annualized. The dividend yield was approximately 1.5 percent based on a share price near $560 in late 2024.
| Dividend Metric | Value (FY2024) |
|---|---|
| Quarterly dividend per share | $2.10 |
| Annualized dividend per share | $8.40 |
| Approximate dividend yield | approximately 1.5% (at approx. $560/share) |
| Total dividends paid FY2024 | approximately $7.9 billion |
| Consecutive years of dividend increases | more than 15 years |
| Dividend cuts or suspensions | None in recent history |
The dividend payout ratio is deliberately kept moderate. UnitedHealth management has consistently stated a preference for maintaining financial flexibility through a lower payout ratio so that operating cash flow can fund share buybacks and acquisitions. This policy means the dividend yield appears low relative to traditional defensive healthcare peers, but the total capital return to shareholders through the buyback program is substantial.
Share repurchases
UnitedHealth consistently returns a large share of operating cash flow to shareholders through buybacks. The company has steadily reduced its diluted share count over time, which amplifies earnings per share growth above net income growth. In fiscal year 2024, UnitedHealth repurchased approximately $6.8 billion of its own stock.
| Capital Return (FY2024) | Approximate Amount |
|---|---|
| Share repurchases | approximately $6.8 billion |
| Dividends paid | approximately $7.9 billion |
| Combined capital return | approximately $14.7 billion |
| Target capital return ratio | more than 80% of operating cash flow (stated policy) |
The company's stated capital allocation policy targets returning more than 80 percent of operating cash flow to shareholders through the combined dividend and buyback program. This policy has generally been met in recent fiscal years. The balance of operating cash flow supports acquisitions, organic investment in Optum capabilities, and balance sheet maintenance. Elevated medical cost ratios in 2024 and 2025 created some pressure on near-term free cash flow, but the structural capital return commitment remained in place.
Market capitalization and scale
As of late 2024, UnitedHealth Group had a market capitalization of approximately $525 billion based on a share price near $560 and approximately 940 million diluted shares outstanding. This places UNH among the ten largest companies in the S&P 500 by market capitalization and makes it the largest component of the healthcare sector.
| Market Cap Metric | Value (late 2024 approximate) |
|---|---|
| Approximate share price | approximately $560 |
| Approximate diluted shares outstanding | approximately 940 million |
| Approximate market capitalization | approximately $525 billion |
Revenue at UnitedHealth Group exceeds $370 billion annually, making it one of the largest companies in the United States by revenue. The insurance business operates on thin net margins, but Optum's higher-margin services business has lifted the blended operating margin meaningfully above what a pure insurer would report.
Valuation framework
Evaluating UnitedHealth Group requires separating the insurance (UnitedHealthcare) and services (Optum) segments, as each has different margin profiles, growth dynamics, and appropriate valuation benchmarks.
Price-to-earnings
UnitedHealth historically traded in a forward P/E range of 16 to 22 times adjusted earnings. The FY2025 consensus for adjusted EPS was approximately $27.50 to $29.00 as of late 2024, suggesting a forward P/E at the upper end of the historical range near 20 times. The upper end reflects elevated uncertainty around the medical cost ratio. UNH's medical cost ratio increased in 2024 and 2025, compressing near-term earnings and causing the forward P/E to expand as the earnings denominator declined relative to the share price. Investors who view the elevated medical cost ratio as cyclical rather than structural tend to normalize earnings to a lower claims environment and apply a lower P/E to that normalized figure.
EV/EBITDA
An enterprise value to EBITDA multiple of approximately 16 times reflects both the insurance segment's low-margin, high-revenue base and Optum's higher-margin services contribution. Because insurance revenue is large relative to EBITDA, the EV/EBITDA multiple is more useful for peer comparisons within managed care (Cigna, Elevance, CVS Health's insurance segment) than for cross-sector comparisons.
Price-to-sales
A price-to-sales ratio of approximately 1.3 times is expected for a company where most of the revenue flows through as medical claims and pharmacy costs. Insurance economics produce thin net margins on very large revenue bases. The P/S ratio is most useful for confirming that the premium for UNH's quality is not extreme relative to the revenue scale, not for establishing an intrinsic value independently.
Segment-level analysis
More granular valuation work separates UnitedHealthcare (managed care, benchmarked against peers on medical cost ratio and membership growth) from Optum (pharmacy benefit management, analytics, and care delivery, benchmarked on operating margin and script volume). Optum's contribution has grown substantially as a share of total operating earnings and has historically commanded a higher multiple than managed care alone, supporting a blended valuation above what a pure insurer peer would receive.
Frequently Asked Questions
When did UnitedHealth Group go public and list on the NYSE?
UnitedHealth Group first listed on the New York Stock Exchange in 1977. The company took its current corporate form as UnitedHealth Group in 1998 following a rebranding. Its SEC CIK number is 0000731766. UNH has traded on the NYSE under the ticker UNH since those early years and has remained one of the exchange's largest healthcare listings by market capitalization.
Has UnitedHealth stock been split?
Yes, UnitedHealth Group has completed four stock splits. The first was a 2-for-1 split on May 1, 1992. The second was a 3-for-2 split on November 1, 1995. The third was a 3-for-2 split on May 14, 1997. The fourth was a 2-for-1 split on January 10, 2000. The cumulative split factor is 9x (calculated as 2 times 1.5 times 1.5 times 2), meaning one pre-1992 share became nine shares after all four splits were complete.
When was UnitedHealth added to the Dow Jones Industrial Average?
UnitedHealth Group was added to the Dow Jones Industrial Average on September 24, 2012, replacing Kraft Foods. Because the DJIA is a price-weighted index, UnitedHealth's high per-share price of $550 or more has at times made it the single largest influence on the index's daily point movement, giving UNH an outsized effect on the Dow compared to lower-priced components.
How does UnitedHealth Group return capital to shareholders?
UnitedHealth returns capital through quarterly dividends and share repurchases. The quarterly dividend was $2.10 per share ($8.40 annualized) as of fiscal year 2024, and the company has raised its dividend for more than 15 consecutive years. In fiscal year 2024, UnitedHealth paid approximately $7.9 billion in dividends and repurchased approximately $6.8 billion of its own stock. The company consistently returns more than 80 percent of operating cash flow to shareholders through the combined dividend and buyback program.